Long-term safety and tolerability of ezetimibe coadministered with simvastatin in hypercholesterolemic patients: a randomized, 12-month double-blind extension study

By Strony John   Yang Bo   Hanson Mary E.   Veltri Enrico P.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3149-3157

Informa Healthcare

Access to resources Recommend Favorite

The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia

By Florentin Matilda   Liberopoulos Evangelos N.   Moutzouri Elisavet   Rizos Christos V.   Tselepis Alexandros D.   Elisaf Moses S.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 685-692

Informa Healthcare

Access to resources Recommend Favorite

Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia

By Assmann Gerd   Kannenberg Frank   Ramey Dena R.   Musliner Thomas A.   Gutkin Stephen W.   Veltri Enrico P.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 249-259

Informa Healthcare

Access to resources Recommend Favorite

Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia

By Daskalopoulou Stella S.   Mikhailidis Dimitri P.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2037-2039

Informa Healthcare

Access to resources Recommend Favorite

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

By Colonna Lucien   Andersen Henning Friis   Reines Elin Heldbo  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1659-1668

Informa Healthcare

Access to resources Recommend Favorite